2026-2034年全球心房顫動治療設備市場規模、佔有率、趨勢和成長分析報告

預計到 2034 年，心房顫動治療設備的市場規模將從 2025 年的 162 億美元成長至 445.3 億美元，並預計從 2026 年到 2034 年將以 11.89% 的複合年成長率成長。

由於心血管疾病（尤其是常見的心律不整－心房顫動）的盛行率不斷上升，全球心房顫動治療設備市場正在快速成長。用於治療心房顫動的裝置包括心臟監測系統、消融導管和用於調節心率的植入裝置。這些技術有助於改善心房顫動的診斷、治療和長期管理。

市場成長主要受心臟病發病率上升、人口老化以及心臟治療技術進步的推動。醫療機構正在擴大微創手術和先進醫療設備的應用，以改善心房顫動患者的治療效果。此外，對心血管研究和醫療基礎設施投入的增加也促進了該市場的擴張。

展望未來，由於醫療技術的不斷進步和對有效心臟治療需求的不斷成長，心房顫動治療設備市場預計將持續成長。電生理設備、穿戴式心率監測系統和導管介入手術的創新將進一步拓展治療選擇。公眾意識的提高和診斷能力的提升預計將推動市場持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球心房顫動治療設備市場：依產品分類

• 市場分析、洞察與預測
• 電生理消融導管
• 心臟監測儀或植入式循環記錄儀
• 電生理診斷導管
• 地圖繪製與記錄系統
• 存取裝置
• 經心超音波心臟檢查（ICE）
• 左心耳封堵裝置
• 其他產品

第5章：全球心房顫動治療設備市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 心臟中心
• 門診手術中心
• 其他最終用戶

第6章 全球心房顫動治療設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • Acutus Medical Inc
  • AtriCure Inc
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardioFocus Inc
  • CathRx Ltd
  • Hansen Medical Inc
  • Imricor Medical Systems Inc
  • Johnson & Johnson（Biosense Webster）
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Osypka Medical GmbH
  • Stryker Corporation
  • Synaptic Medical

The Atrial Fibrillation Devices Market size is expected to reach USD 44.53 Billion in 2034 from USD 16.20 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.

The Global Atrial Fibrillation Devices Market is growing rapidly due to the increasing prevalence of cardiovascular disorders, particularly atrial fibrillation (AF), a common heart rhythm disorder. Devices used in the management of atrial fibrillation include cardiac monitoring systems, ablation catheters, and implantable devices designed to regulate heart rhythm. These technologies help improve diagnosis, treatment, and long-term management of the condition.

Market growth is driven by the rising incidence of heart diseases, an aging population, and advancements in cardiac treatment technologies. Healthcare providers are increasingly adopting minimally invasive procedures and advanced medical devices to improve treatment outcomes for patients with atrial fibrillation. Additionally, growing investments in cardiovascular research and healthcare infrastructure are supporting the expansion of this market.

Looking forward, the atrial fibrillation devices market is expected to grow as medical technologies continue to advance and demand for effective cardiac treatments increases. Innovations in electrophysiology devices, wearable heart monitoring systems, and catheter-based procedures will further enhance treatment options. With increasing awareness and improved diagnostic capabilities, the market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• EP Ablation Catheters
• Cardiac Monitors or Implantable Loop Recorder
• EP Diagnostic Catheters
• Mapping and Recording Systems
• Access Devices
• Intracardiac Echocardiography (ICE)
• Left Atrial Appendage (LAA) Closure Devices
• Other Products

By End Use

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Abbott Laboratories, Acutus Medical Inc, AtriCure Inc, Biotronik SE Co KG, Boston Scientific Corporation, CardioFocus Inc, CathRx Ltd, Hansen Medical Inc, Imricor Medical Systems Inc, Johnson Johnson Biosense Webster, Medtronic plc, MicroPort Scientific Corporation, Osypka Medical GmbH, Stryker Corporation, Synaptic Medical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. EP Ablation Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cardiac Monitors or Implantable Loop Recorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. EP Diagnostic Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Mapping and Recording Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Access Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Intracardiac Echocardiography (ICE) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Left Atrial Appendage (LAA) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ATRIAL FIBRILLATION DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 Acutus Medical Inc
  • 8.2.3 AtriCure Inc
  • 8.2.4 Biotronik SE & Co. KG
  • 8.2.5 Boston Scientific Corporation
  • 8.2.6 CardioFocus Inc
  • 8.2.7 CathRx Ltd
  • 8.2.8 Hansen Medical Inc
  • 8.2.9 Imricor Medical Systems Inc
  • 8.2.10 Johnson & Johnson (Biosense Webster)
  • 8.2.11 Medtronic Plc
  • 8.2.12 MicroPort Scientific Corporation
  • 8.2.13 Osypka Medical GmbH
  • 8.2.14 Stryker Corporation
  • 8.2.15 Synaptic Medical